Plain-English translation of NCT06646198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination approach for advanced liver cancer: first, doctors perform a procedure called TIPS (a shunt that redirects blood flow in the liver), and then you take a medication called at half the standard dose. The study wants to see whether this combination can shrink tumors and improve outcomes for people whose cancer has spread to major blood vessels in the liver.
Advanced liver cancer that has spread to blood vessels is very difficult to treat, and people often develop serious complications like bleeding and fluid buildup in the abdomen. This trial exists to test whether combining a blood-flow procedure with this medication might help control both the cancer and these dangerous complications.
You likely qualify if…
You likely don't qualify if…
You would first undergo the TIPS procedure, which is a minimally invasive intervention where doctors place a shunt to improve blood flow in your liver. After that, you would take the medication at a reduced dose and continue treatment until your cancer progresses, you experience unacceptable side effects, or your doctor determines you should stop. The trial will monitor your response with imaging scans and blood tests to measure how well the treatment is working and track any side effects.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
China